GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CBT · Jun 30, 2026

CABOT CORP. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 4[email protected]
Inspectable configuration

State dimensions

Filing0001193125-26-332489General Corporate
Debt relative to revenue60thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.debt_to_revenue

129.63% · OPTIONAL · VALID

Capex intensity15thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

3.87% · OPTIONAL · VALID

Operating cash generation30thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

7.64% · OPTIONAL · VALID

Revenue growth70thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.revenue

6.39% · CORE · VALID

Inventory pressure55thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

57.64% · OPTIONAL · VALID

Gross margin0thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.gross_margin

18.74% · CORE · VALID

Operating margin10thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.operating_margin

9.98% · CORE · VALID

R&D intensity20thOwn-history percentile · N=20
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

1.32% · OPTIONAL · VALID

SBC intensity50thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

0.61% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History36 statesSelf-history eligible
Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Dec 31, 20239/9 normalizedLevel 3Mar 31, 20249/9 normalizedLevel 3Jun 30, 20249/9 normalizedLevel 3Sep 30, 20249/9 normalizedLevel 3Dec 31, 20249/9 normalizedLevel 3Mar 31, 20259/9 normalizedLevel 3Jun 30, 20259/9 normalizedLevel 3Sep 30, 20259/9 normalizedLevel 3Dec 31, 20259/9 normalizedLevel 3Mar 31, 20269/9 normalizedLevel 3Jun 30, 20269/9 normalizedLevel 4
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
143.69%
Current
129.63%
Delta
-14.06%
Capex Intensity Decreased
Previous
4.98%
Current
3.87%
Delta
-1.11%
Cash Generation Decreased
Previous
8.52%
Current
7.64%
Delta
-0.88%
Growth Increased
Previous
-3.42%
Current
6.39%
Delta
9.81%
Inventory Pressure Decreased
Previous
57.74%
Current
57.64%
Delta
-0.11%
Margin Decreased
Previous
23.23%
Current
18.74%
Delta
-4.49%
Profitability Decreased
Previous
14.27%
Current
9.98%
Delta
-4.29%
R And D Intensity Decreased
Previous
1.55%
Current
1.32%
Delta
-0.22%
Sbc Intensity Increased
Previous
0.44%
Current
0.61%
Delta
0.17%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Dec 31, 2021
Similarity
82%
Compared
9 dimensions
Coverage
100%
Growth 14.6 · Margin 29.4 · Profitability 4.1 · Sbc Intensity 20.6 · Capex Intensity 15.0 · Cash Generation 30.0 · R And D Intensity 14.1 · Inventory Pressure 7.9 · Balance Sheet Leverage 4.7
Dec 31, 2022
Similarity
72%
Compared
9 dimensions
Coverage
100%
Growth 40.6 · Margin 5.0 · Profitability 50.0 · Sbc Intensity 25.0 · Capex Intensity 10.0 · Cash Generation 10.0 · R And D Intensity 5.0 · Inventory Pressure 40.0 · Balance Sheet Leverage 15.0
Jun 30, 2022
Similarity
72%
Compared
9 dimensions
Coverage
100%
Growth 3.3 · Margin 26.3 · Profitability 74.2 · Sbc Intensity 2.6 · Capex Intensity 0.8 · Cash Generation 8.9 · R And D Intensity 20.0 · Inventory Pressure 2.4 · Balance Sheet Leverage 17.9
Mar 31, 2026
Similarity
69%
Compared
9 dimensions
Coverage
100%
Growth 35.0 · Margin 45.0 · Profitability 25.0 · Sbc Intensity 40.0 · Capex Intensity 25.0 · Cash Generation 15.0 · R And D Intensity 35.0 · Inventory Pressure 5.0 · Balance Sheet Leverage 35.0
Sep 30, 2019
Similarity
64%
Compared
8 dimensions
Coverage
89%
Margin 25.0 · Profitability 27.5 · Sbc Intensity 37.5 · Capex Intensity 22.5 · Cash Generation 45.0 · R And D Intensity 7.5 · Inventory Pressure 55.0 · Balance Sheet Leverage 47.5
Research Graph

Related governed research

Analogous To · CBT state analogue 3 →Analogous To · CBT state analogue 4 →Analogous To · CBT state analogue 5 →Analogous To · CBT state analogue 2 →Compared To · Miscellaneous Chemical Products peers →Analogous To · CBT state analogue 1 →Has State · CABOT CORP →Transitioned To · CBT Fundamental State →Transitioned To · CBT BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · CBT CAPEX_INTENSITY_DECREASED →Transitioned To · CBT CASH_GENERATION_DECREASED →Transitioned To · CBT GROWTH_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.